Age-related fertility decline (ARFD) is a prevalent concern amongst western cultures due to
the increasing age of first-time motherhood. Elective oocyte and embryo cryopreservation …

The scope of female fertility preservation through cryopreservation of oocytes or ovarian
cortex has widened from mainly oncological indications to a variety of fertility-threatening …

Recent advances in oocyte and ovarian tissue cryopreservation technology have brought
hope not only to women facing premature loss of ovarian function, but also to healthy …

Reproductive aging is a natural process that occurs in all women, eventually leading to
reproductive senescence and menopause. Over the past half century there has been a trend …

Oocyte cryopreservation provides women with an option to defer childbearing and maintain
reproductive autonomy, with IVF success rates on par with fresh IVF. However, it is critical …

Purpose Women who pursue fertility at an advanced age are increasingly common. Family
planning and sexual education have traditionally focused on contraception and prevention …

Female fertility preservation provides significantly different challenges to that for the male,
with the only established method being cryopreservation of embryos thus necessitating the …

Background The utilization of oocyte cryopreservation (OC) has become popularized with
increasing numbers of reproductive-aged patients desiring to maintain fertility for future …

Along with improved survival, methods to preserve or restore the fertility potential of young
women and children treated with cytotoxic chemotherapy or pelvic radiotherapy have been …

With an upward trend in delaying parenthood, women across the world face an increasing
risk of age-related infertility and involuntary childlessness. Elective oocyte banking …